Table of Contents
What changed
Revenue fell 45% to NZ$9.9m from NZ$18.0m in HY20, reflecting a materially reduced visitor base across the hospitality footprint against a COVID-affected prior period that included the first-time contribution of the acquired hospitality business. Despite the top-line contraction, reported EBITDA (stated before restructuring costs) more than doubled to NZ$0.7m from NZ$0.3m, and the bottom-line loss narrowed to NZ$(0.4)m from NZ$(1.6)m, a 74% reduction. Operating cash flow, however, moved the other way, turning negative at NZ$(0.1)m. The cash balance rose nearly tenfold to NZ$3.7m (from NZ$0.4m), total liabilities fell NZ$9.6m to NZ$23.5m, and equity strengthened to NZ$18.6m from NZ$13.2m, consistent with an equity injection rather than earnings generation. No dividend has been declared (payment date stated as not applicable).
What matters
- Cost base has been resized, but the operating read is fragile. EBITDA roughly doubled on revenue that nearly halved, implying meaningful cost take-out. With PBT and NPAT identical at NZ$(0.4)m (nil tax expense), PBT growth of 74% is the cleanest earnings read and materially better than HY20 — but still a loss.
- Balance sheet is directionally stronger, funded by equity not operations. Net debt fell to NZ$5.2m from NZ$7.6m, and net debt / EBITDA dropped to 7.5x from 22.9x. The step-up in cash and equity is consistent with a capital raise rather than internally generated cash, given operating cash flow was negative.
- Cash conversion deteriorated sharply. Operating cash flow at NZ$(0.1)m against EBITDA of NZ$0.7m (OCF/EBITDA of -20.8% versus 655.3% in HY20) is a direct flag: the reported earnings improvement has not translated to cash.
Expectations
No stated targets or quantified forward-work metrics were provided. The only forward commentary in the supplied excerpts is qualitative — "trading has continued to improve heading into the Christmas period, with sales above expectations." HY20 represented 47.1% of FY20 revenue (with FY20's second half actually weaker on EBITDA at an implied NZ$(2.3)m), so there is no reliable seasonality anchor to extrapolate from. Annualised HY21 revenue of NZ$19.8m sits at roughly 52% of FY20's NZ$38.3m and slightly below FY20's implied H2 revenue of NZ$20.3m, suggesting the business is currently running at a materially smaller scale than the FY20 run-rate. The release does not support a view on whether that gap is closed in H2.
Quality of result
Modest. The earnings improvement is real but the underlying operation generated negative cash despite positive EBITDA, and there is no supplied bridge from statutory profit to the non-GAAP EBITDA (which is stated before restructuring costs). Working capital helped on the receivables side — trade debtors collapsed 94.7% to NZ$0.2m and receivable days fell to 4 from 15 — but inventory days rose, and operating working capital reduction of NZ$2.1m did not flow through to cash in the way EBITDA would normally imply. Capex of NZ$0.4m was lower than prior, producing pre-lease free cash flow of NZ$(0.6)m versus NZ$1.3m in HY20. The balance-sheet improvement looks driven by fresh equity rather than trading.
Unresolved
- What portion of the EBITDA uplift is structural cost reduction versus temporary COVID-period savings (rent relief, wage subsidies, deferred spend)?
- Why did operating cash flow deteriorate so materially against a higher EBITDA — is there a timing item, restructuring cash outflow, or lease treatment driving the gap?
- What were the terms and size of the equity injection implied by the NZ$5.4m rise in equity, and how should that re-base the share count for per-share metrics?
- What is the composition of gross borrowings of NZ$8.9m (overdraft NZ$1.4m plus NZ$7.4m of borrowings), and what are the covenant and maturity profiles?
- Neither segment-level disclosure nor forward bookings/forward-work metrics were provided, so the contribution of beverages versus hospitality cannot be disentangled.
This briefing cannot assess valuation, capital-raise pricing, or the sustainability of the improved cost base from the supplied materials alone.
Key metrics
| Metric | HY21 | HY20 | Change |
|---|---|---|---|
| Revenue | $9.9m | $18.0m | -45.0% ↓ |
| EBITDA | $0.7m | $0.3m | +106.0% ↑ |
| Net profit after tax | −$0.4m | −$1.6m | +74.1% ↑ |
| Net cash inflow from operating activities | −$0.1m | — | — |
| Interim dividend per share | 16.0c | 31.0c | -48.4% ↓ |
| Cash and cash equivalents | $3.7m | $0.4m | +840.1% ↑ |
| Total assets | $42.1m | $46.3m | -8.9% ↓ |
Reference: annolyse.ai/briefings/svr-hy21
Analytical metrics
| Metric | HY21 | HY20 | Context |
|---|---|---|---|
| OCF / EBITDA (cash conversion) | -20.8% | 655.3% | deteriorated |
| FCF pre-lease | −$0.6m | $1.3m | −$1.9m |
| FCF / NPAT | 135.4% | -83.3% | complementary conversion metric |
| Capex % revenue | 4.2% | 4.7% | — |
| Capex | −$0.4m | — | — |
| Debtor days | 4.0 | 15.4 | -11.4 days |
| Inventory days | 28.0 | 23.2 | +4.8 days |
| Operating working capital | $1.7m | $3.8m | −$2.1m absorbed |
| Trade debtors | $0.2m | $4087.0m | −$4086.8m |
| Net debt | $5.2m | $7.6m | −$2.5m |
| Net debt / EBITDA | 7.50x | 22.90x | Strengthening |
| Gross borrowings | $8.9m | — | — |
| ROE (annualised) | -2.2% | -12.2% | Strengthening |
| HY20 share of FY20 revenue | 47.1% | — | Other half was 52.9% |
| HY20 share of FY20 NPAT | 39.7% | — | Other half was 60.3% |
| Profit from continuing operations | −$0.4m | −$1605.0m | +$1604.6m |
Reference: annolyse.ai/briefings/svr-hy21
This analysis was generated using Annolyse, an AI-powered tool that extracts and analyses NZX company announcements. The underlying data is extracted from official company filings and verified against source documents. This is general information only and does not constitute financial advice. The analysis may contain errors. Always read the original company filings and consult a licensed financial adviser before making investment decisions.